Delivery Order SPE2DB20D1100-SPE2DB23FC4X0
Award Date 7/10/23
Potential Completion Date 7/31/23
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $11,815.63 delivery order to AmerisourceBergen Drug Corp for the supply of Bosulif 400 mg tablets (30-count units) under a firm fixed price contract type. The delivery order was competitively awarded without a set-aside designation and carries an ultimate completion date of July 24, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply transaction. This delivery order is...
- The Defense Logistics Agency awarded a $11,815.63 delivery order to AmerisourceBergen Drug Corp for BOSULIF 400 mg tablets (30-count units) on September 2, 2025, with an ultimate completion date of September 23, 2025. This firm fixed-price contract, utilizing no set-aside designation, represents a competitive award under the company's broader pharmaceutical supply agreements with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $11,239.34 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4562473623 BOSULIF 400 MG TABLET 30S. The place of performance will be in Conshohocken, Pennsylvania, with all items to be delivered by November 3, 2023. No set-aside designation was used for this procurement. As the Defense Logistics Agency is responsible for worldwide logistics support of the United...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,704.45 on July 2, 2025, for the supply of Bosulif 100 mg tablets (120-count units). This firm fixed-price, competitively awarded contract, which is non-set-aside, will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of July 24, 2025. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of BOSULIF 400 mg tablets (30-count packages) under a firm fixed-price contract structure. The delivery order, valued at $11,815.63, is set to be completed by September 16, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. This award represents a non-set-aside competitive procurement, reflecting AmerisourceBergen's established capability as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,408.90 to AmerisourceBergen Drug Corp for the supply of Bosulif 100 mg tablets (120-count units). This firm fixed-price contract, awarded on August 13, 2025, with an ultimate completion date of September 4, 2025, represents a non-set-aside, competitively awarded procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Bosulif is a prescription oncology...
- The Defense Logistics Agency awarded a delivery order valued at $11,408.90 to AmerisourceBergen Drug Corp for the supply of Bosulif 100 mg tablets (120-count) on August 21, 2025, with completion expected by September 12, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $11,239 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562345909 BOSULIF 400 MG TABLET 30S. As the prime contractor, Amerisourcebergen will supply the pharmaceutical products to the DLA under a schedule contract vehicle. No subcontractors or set aside designations were indicated. The Defense Logistics Agency supports America's armed forces by providing supplies in healthcare, industrial plant equipment, and fuel globally. This...
- The Defense Logistics Agency awarded a $11,239.34 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4562447812 Bosulif 400 MG tablets. The contract has no set-aside designation and requires delivery of 30 tablets to Conshohocken, Pennsylvania by November 1, 2023. As the Defense Logistics Agency is responsible for procuring pharmaceuticals and medical supplies for the U.S. military and other government agencies,...
- The Defense Logistics Agency Troop Support Medical awarded a $45,000 delivery order to Amerisourcebergen Drug Corporation for 400 mg tablets of Bosulif. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 30 tablets of the cancer treatment drug to a facility in Conshohocken, Pennsylvania, with performance required between August 21 and September 12 of this year. No set-aside designation or subcontractors were identified. The Defense Logistics Agency manages the...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB23FC4X0Delivery Order
The Defense Logistics Agency awarded a $11,239 delivery order to Amerisourcebergen Drug Corporation for 4561453229 BOSULIF 400 MG TABLET 30S. This firm fixed price order is being performed under DLA's Prime Vendor Pharmaceuticals contract vehicle, which provides pharmaceuticals and other medical supplies for various DOD programs. Amerisourcebergen will deliver the specified drugs to a location in Conshohocken, Pennsylvania by July 31, 2023 to support DLA requirements. No subcontractors or set aside designations were identified. This order helps ensure DLA can provide needed pharmaceuticals to support the health and readiness of military members.
Generated 12/24/23, 4:53 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 7/10/23 |